Listed on
(Coverage)
JCR2019-2023
SJR2017-2020;2022-2023
CiteScore2017-2023
SCIE2019-2024
CC2019-2024
SCOPUS2018-2024
MEDLINE2017-2024
DOAJ2017-2024
EMBASE2016-2024
OA Info.
| OA |
oa mark
based on the information
- 2017;2018;2019;2020;2021;2022;2023;2024;2025;
|
| Keywords |
perspectives, pharmacology, replication studies, target validation |
| Review Process |
Peer review |
Journal info.
pages |
|
| Licences |
CC BY, CC BY-NC, CC BY-NC-ND |
| Copyrights |
No |
| DOAJ Coverage |
Added on Date : 2016-01-26T18:12:26Z |
| Subject(s) |
Medicine: Therapeutics. Pharmacology |
Country
ENGLAND
Aime & Scopes
PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS.
